Earnings History Data for Rocket Pharmaceuticals, Inc. (RCKT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2023 | AH | RCKT | Rocket Pharmaceuticals | 1,547 | -0.75 | -0.82 | 0.00 | Rocket Pharmaceuticals GAAP EPS of -$0.75 beats by $0.07 [11/6/2023 5:49 PM] |
20.45 | 0.52 (2.61%) |
19.93 | 0.0 (0.00%) |
14.89 - 24.65 | 467,053 | 1,130,000 | 269,420 | ||
| 10-08-2023 | PM | RCKT | Rocket Pharmaceuticals | 1,339 | -0.82 | -0.80 | 0.00 | Rocket Pharmaceuticals GAAP EPS of -$0.82 in-line [8/10/2023 11:03 AM] |
16.76 | -0.20 (-1.18%) |
0.0 | 0.0 (0.00%) |
11.78 - 24.53 | 481,261 | 570,000 | 0 | ||
| 27-02-2023 | AH | RCKT | Rocket Pharmaceuticals | 1,425 | -0.92 | -0.81 | 0.00 | Rocket Pharmaceuticals GAAP EPS of -$0.92 misses by $0.10 [2/27/2023 4:36 PM] |
19.17 | 0.71 (3.85%) |
18.14 | -0.32 (-1.73%) |
7.57 - 23.48 | 652,886 | 690,000 | 376 | ||
| 05-05-2022 | AH | RCKT | Rocket Pharmaceuticals | 690.00 | -0.67 | -0.70 | 0.00 | Rocket Pharmaceuticals GAAP EPS of -$0.67 beats by $0.03 [5/5/2022 5:45 PM] |
9.45 | -0.55 (-5.50%) |
10.50 | 0.50 (5.00%) |
9.29 - 49.66 | 663,170 | 570,000 | 100 | ||
| 09-08-2021 | AH | 4:00 PM ET (Aug 9) |
RCKT | Rocket Pharmaceuticals, Inc. | 2,270 | -0.55 | -0.66 | -0.45 | Rocket Pharmaceuticals EPS beats by $0.11 [8/9/2021 4:14 PM] |
33.06 | -0.56 (-1.68%) |
33.60 | -0.03 (-0.09%) |
21.95 - 67.48 | 507,712 | 540,000 | 424 | |
| 04-11-2020 | PM | RCKT | Inotek Pharmaceuticals Corporation | 1,581 | -0.53 | -0.46 | 0.00 | Rocket Pharmaceuticals EPS misses by $0.06 [11/4/2020 7:12 AM] |
31.53 | 2.15 (7.32%) |
0.0 | 0.0 (0.00%) |
9.01 - 34.00 | 535,948 | 235,592 | 0 | ||
|
|
||||||||||||||||||
| 04-11-2020 | PM | RCKT | Rocket Pharmaceuticals, Inc. | 1,620 | -0.53 | -0.46 | -0.38 | Rocket Pharmaceuticals EPS misses by $0.06 [11/4/2020 7:12 AM] |
28.87 | -2.07 (-6.69%) |
28.87 | 0.0 (0.00%) |
9.01 - 34.00 | 195,332 | 324,470 | 3,342 | ||
|
|
||||||||||||||||||
| 05-08-2020 | PM | 7:00 AM ET (Aug 5) |
RCKT | Rocket Pharmaceuticals, Inc. | 1,300 | -0.45 | -0.51 | -0.38 | Rocket Pharmaceuticals EPS beats by $0.06 [8/5/2020 7:46 AM] |
26.64 | 1.38 (5.46%) |
25.80 | 0.54 (2.14%) |
9.01 - 27.59 | 254,199 | 325,880 | 1,725 | |
|
|
||||||||||||||||||